Scout Bio

Philadelphia, United States Founded: 2017 • Age: 9 yrs Acquired By Ceva
Manufacturer of protein therapeutics for animal health
Request Access

About Scout Bio

Scout Bio is a company based in Philadelphia (United States) founded in 2017 was acquired by Ceva in January 2024.. Scout Bio has raised $29.3 million across 2 funding rounds from investors including Ceva, Frazier Healthcare Partners and Greenspring Associates. Scout Bio offers products and services including AAV Vector Gene Therapy and Therapy for CKD Anemia.

  • Headquarter Philadelphia, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Legal Name Scout Bio, Inc.
Operational Areas
Healthcare → Veterinary & Animal Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $29.3 M (USD)

    in 2 rounds

  • Latest Funding Round
    $20 M (USD), Series B

    Apr 11, 2019

  • Investors
    Ceva

    & 6 more

  • Employee Count
    Employee Count
  • Acquired by
    Ceva

    (Jan 25, 2024)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Scout Bio

Scout Bio offers a comprehensive portfolio of products and services, including AAV Vector Gene Therapy and Therapy for CKD Anemia. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

One-time injection for long-lasting expression of therapeutic proteins in pets

Targets anemia in cats with chronic kidney disease through gene transfer

People of Scout Bio
Headcount 1-10
Employee Profiles 4
Employee Profiles
People
Alex Kau
VP Finance

Unlock access to complete

Funding Insights of Scout Bio

Scout Bio has successfully raised a total of $29.3M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $20 million completed in April 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series B — $20.0M
  • First Round

    (27 Mar 2018)

  • Investors Count 6
Date Amount Transaction Name Valuation Lead Investors Investors
Apr, 2019 Amount Series B - Scout Bio Valuation Companion Fund , RiverVest Venture Partners
Mar, 2018 Amount Series A - Scout Bio Valuation Frazier Healthcare Partners
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Scout Bio

Scout Bio has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Ceva, Frazier Healthcare Partners and Greenspring Associates. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investment in animal health innovation is facilitated by Digitalis Ventures.
Founded Year Domain Location
-
Founded Year Domain Location
Diversified investment management firm
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Scout Bio

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Scout Bio

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Scout Bio Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Scout Bio

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Scout Bio

Frequently Asked Questions about Scout Bio

When was Scout Bio founded?

Scout Bio was founded in 2017 and raised its 1st funding round 1 year after it was founded.

Where is Scout Bio located?

Scout Bio is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.

Who is the current CEO of Scout Bio?

Mark Heffernan is the current CEO of Scout Bio.

Is Scout Bio a funded company?

Scout Bio is a funded company, having raised a total of $29.3M across 2 funding rounds to date. The company's 1st funding round was a Series A of $9.3M, raised on Mar 27, 2018.

What does Scout Bio do?

Scout Bio was founded in 2017 in Philadelphia, United States, within the biotechnology sector focused on animal health. Gene therapy technologies are developed to address chronic conditions in pets through protein therapeutics. An adeno-associated viral (AAV) vector process is utilized, involving intramuscular injections to enable expression of therapeutic proteins. Operations center on advancing these treatments for veterinary applications.

What products or services does Scout Bio offer?

Scout Bio offers AAV Vector Gene Therapy and Therapy for CKD Anemia.

Who are Scout Bio's investors?

Scout Bio has 7 investors. Key investors include Ceva, Frazier Healthcare Partners, Greenspring Associates, Digitalis Ventures, and RiverVest Venture Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available